You are here
-
EBV Early Antigen [1108-1]
Description Epstein-Barr virus (EBV), also designated human herpesvirus 4 (HHV-4), is one of eight known viruses in the herpes family, and is one of the most common viruses in humans. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. The EBV-induced early antigens (Ea) are among several antigen complexes that have been identified in EBV-infected cells. The Ea complex is composed of diffuse (Ea-D) and restricted (Ea-R) components. The activity of Ea-D is suppressed during latent infection. BMRF1, the gene that encodes for Ea-D, is closely associated with the gene encoding for EBV DNA polymerase, and Ea-D is essential for the activity of this polymerase. Ea-D forms a complex with EBV DNase and, together, they may play a role in viral replication. (Shipping Cost: €200.00) Host Mouse Application Immunocytochemistry (ICC),Immunofluorescence (IF), Immunohistochemistry (IHC), Immunoprecipitation (IP) Reactivity EBV -
EBV-I3 Polyclonal
Description Epstein-Barr virus-induced gene 3 protein (EBI3), also known as Interleukin-27 subunit beta (IL27B), is a member of the type I cytokine receptor family (Type 3 subfamily) that is composed of two subunits: interleukin-27 (IL-27) and IL-35. EBI3 regulates T-helper cell development, stimulates cytotoxic T-cell activity, suppresses T-cell proliferation, and induces isotype switching in B-cells. EBI3 also plays an important role in its antitumor activity as well as its antiangiogenic activity. (Shipping Cost: €200.00) Host Rabbit Application Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blot (WB) Reactivity Human -
EBV-I3 Polyclonal
Description Epstein-Barr virus-induced gene 3 protein (EBI3), also known as Interleukin-27 subunit beta (IL27B), is a member of the type I cytokine receptor family (Type 3 subfamily) that is composed of two subunits: interleukin-27 (IL-27) and IL-35. EBI3 regulates T-helper cell development, stimulates cytotoxic T-cell activity, suppresses T-cell proliferation, and induces isotype switching in B-cells. EBI3 also plays an important role in its antitumor activity as well as its antiangiogenic activity. (Shipping Cost: €200.00) Host Rabbit Application Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blot (WB) Reactivity Human -
EGFR (L858R Mutant Specific) [MD27R]
Description Two types of mutations account for approximately 90% of mutated cases: a specific point mutation, L858R, which occurs in exon 21 and short in-frame deletions in exon 19. A common lesion in exon 19 is the deletion of E746-A750, although other variants occur. IHC-based EGFR E746-A750del specific antibody is designed to detect deletion of E746-A750 in exon 19. Deletion in exon 19 is associated with response of non-small cell lung carcinoma (NSCLC) to gefitinib or erlotinib monotherapy. (Shipping Cost: €200.00) Host Rabbit Application Flow cytometry (FC), Immunofluorescence (IF), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blot (WB) Reactivity Human -
EGFR [GFR/1667]
Description Epidermal growth factor receptor (EGFR) is a 170 kDa transmembrane glycoprotein receptor tyrosine kinase that, activated by epidermal growth factor (EGF), affects cell growth and differentiation. Binding of EGF or TGF alpha to EGFR activates tyrosine kinase activity of the receptor. Phosphorylation of Tyr 992, Tyr 1068 and Tyr 1086 is required for conformational change in the C-terminal of EGFR. Autophosphorylation of Tyr 992 creates a binding site for the phospholipase C-gamma (PLC-gamma) SH2 domain, inducing downstream signaling. In breast cancer, EGFR is predorminately expressed in basal cell-like carcinoma, it has been recommendated for identification of basal-like breast carcinoma along with Cytokeratin 5/6. (Shipping Cost: €200.00) Host Mouse Application Flow cytometry (FC), Immunocytochemistry (ICC),Immunofluorescence (IF), Immunohistochemistry (IHC) Reactivity Human -
EGFR [GFR/1667]
Description Epidermal growth factor receptor (EGFR) is a 170 kDa transmembrane glycoprotein receptor tyrosine kinase that, activated by epidermal growth factor (EGF), affects cell growth and differentiation. Binding of EGF or TGF alpha to EGFR activates tyrosine kinase activity of the receptor. Phosphorylation of Tyr 992, Tyr 1068 and Tyr 1086 is required for conformational change in the C-terminal of EGFR. Autophosphorylation of Tyr 992 creates a binding site for the phospholipase C-gamma (PLC-gamma) SH2 domain, inducing downstream signaling. In breast cancer, EGFR is predorminately expressed in basal cell-like carcinoma, it has been recommendated for identification of basal-like breast carcinoma along with Cytokeratin 5/6. (Shipping Cost: €200.00) Host Mouse Application Flow cytometry (FC), Immunocytochemistry (ICC),Immunofluorescence (IF), Immunohistochemistry (IHC) Reactivity Human -
EMA/CA15.3/MUC1/Episialin/CD227 [139H2]
Description Mucins are a family of heavily glycosylated high molecular weight glycoproteins. Total 21 mucins have been identified to date. Mucins are well known for its involvement in the protection and lubrication of luminal epithelial surfaces. MUC1, a transmembrane mucins, has been shown to be involved in several signaling pathways, including Ras, beta-catenin, p120 catenin, p53 and estrogen receptor alpha. When MUC1 forms a complex with beta-catenin, it enters the nucleus to activate T-cell factor/leukocyte enhancing factor 1 transcription factors and gene expression. In addition, MUC1 may inhibit cell-cell and cell-stroma interactions and function as a signal transducer, participating in cancer progression. MUC1 is expressed in many types of epithelial cell in gastrointerstinal tract, lung, breast, pancreas and genitourinary tract. MUC1 is also detected in activated and unactivated T-cells. In some tumors derived from epithelial cells, MUC1 expression is associated with tumor type and invasiv Host Mouse Application ELISA, Flow cytometry (FC), Immunofluorescence (IF), Immunohistochemistry (IHC) Reactivity Human, Mouse -
EMA/CA15.3/MUC1/Episialin/CD227 [139H2]
Description Mucins are a family of heavily glycosylated high molecular weight glycoproteins. Total 21 mucins have been identified to date. Mucins are well known for its involvement in the protection and lubrication of luminal epithelial surfaces. MUC1, a transmembrane mucins, has been shown to be involved in several signaling pathways, including Ras, beta-catenin, p120 catenin, p53 and estrogen receptor alpha. When MUC1 forms a complex with beta-catenin, it enters the nucleus to activate T-cell factor/leukocyte enhancing factor 1 transcription factors and gene expression. In addition, MUC1 may inhibit cell-cell and cell-stroma interactions and function as a signal transducer, participating in cancer progression. MUC1 is expressed in many types of epithelial cell in gastrointerstinal tract, lung, breast, pancreas and genitourinary tract. MUC1 is also detected in activated and unactivated T-cells. In some tumors derived from epithelial cells, MUC1 expression is associated with tumor type and invasiv Host Mouse Application ELISA, Flow cytometry (FC), Immunofluorescence (IF), Immunohistochemistry (IHC) Reactivity Human, Mouse -
EMA/CA15.3/MUC1/Episialin/CD227 [SPM492]
Description Mucins are a family of heavily glycosylated high molecular weight glycoproteins. Total 21 mucins have been identified to date. Mucins are well known for its involvement in the protection and lubrication of luminal epithelial surfaces. MUC1, a transmembrane mucins, has been shown to be involved in several signaling pathways, including Ras, beta-catenin, p120 catenin, p53 and estrogen receptor alpha. When MUC1 forms a complex with beta-catenin, it enters the nucleus to activate T-cell factor/leukocyte enhancing factor 1 transcription factors and gene expression. In addition, MUC1 may inhibit cell-cell and cell-stroma interactions and function as a signal transducer, participating in cancer progression. MUC1 is expressed in many types of epithelial cell in gastrointerstinal tract, lung, breast, pancreas and genitourinary tract. MUC1 is also detected in activated and unactivated T-cells. In some tumors derived from epithelial cells, MUC1 expression is associated with tumor type and invasiv Host Mouse Application ELISA, Flow cytometry (FC), Immunofluorescence (IF), Immunohistochemistry (IHC) Reactivity Human, Mouse -
EMA/CA15.3/MUC1/Episialin/CD227 [SPM492]
Description Mucins are a family of heavily glycosylated high molecular weight glycoproteins. Total 21 mucins have been identified to date. Mucins are well known for its involvement in the protection and lubrication of luminal epithelial surfaces. MUC1, a transmembrane mucins, has been shown to be involved in several signaling pathways, including Ras, beta-catenin, p120 catenin, p53 and estrogen receptor alpha. When MUC1 forms a complex with beta-catenin, it enters the nucleus to activate T-cell factor/leukocyte enhancing factor 1 transcription factors and gene expression. In addition, MUC1 may inhibit cell-cell and cell-stroma interactions and function as a signal transducer, participating in cancer progression. MUC1 is expressed in many types of epithelial cell in gastrointerstinal tract, lung, breast, pancreas and genitourinary tract. MUC1 is also detected in activated and unactivated T-cells. In some tumors derived from epithelial cells, MUC1 expression is associated with tumor type and invasiv Host Mouse Application ELISA, Flow cytometry (FC), Immunofluorescence (IF), Immunohistochemistry (IHC) Reactivity Human, Mouse